Riskpilot← Back to searchSign inGet full accessSalusos AB
ABActiveOrg 5569110256Gruvgatan 8Hospital activities · NACE 8610Est. 20121-4 employees
Revenue 2025
SEK 4,6M
+28% vs 2024
EBITDA margin
27.6%
+82% vs 2024
Equity ratio
59.0%
Financial strength
Net profit 2025
SEK 908K
+134% vs 2024
| Revenue | SEK 4,6M | +28% |
| EBITDA | SEK 1,3M | +82% |
| Net profit | SEK 908K | +134% |
| Total assets | SEK 5,1M | +8% |
| Equity | SEK 3M | +43% |
| Employees | — | — |
Legal name
Salusos AB
Org number
5569110256
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
20 november 2012
Share capital
SEK 50 000
Employees
1-4
VAT registered
No
Audit selected
No
Last report
2025-09-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Föremålet för bolagets verksamhet är att bedriva hälso-och sjuk- vårdsinriktad verksamhet framför allt inom ortopedi, läkarpraktik och därmed förenlig verksamhet.
Address
Gruvgatan 8
Email
kami.jahani@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 4 691 | 4 115 | 3 726 | 3 616 | 4 610 |
| Staff expenses | — | — | −1 549 | −1 740 | −1 808 |
| EBITDA | 2 302 | 1 763 | 1 118 | 699 | 1 274 |
| Depreciation & amort. | −112 | −131 | −137 | −137 | −96 |
| EBIT | 2 190 | 1 632 | 981 | 561 | 1 179 |
| Net financials | — | −2 | −3 | 48 | 94 |
| Profit before tax | 1 660 | 1 230 | 748 | 504 | 1 167 |
| Tax | −356 | −241 | −162 | −116 | −259 |
| Net profit | 1 304 | 989 | 586 | 389 | 908 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 4 220 | 3 987 | 4 171 | 4 749 | 5 133 |
| Equity | 2 579 | 2 068 | 2 334 | 2 123 | 3 031 |
| Long-term debt | 132 | 136 | 133 | 735 | 132 |
| Short-term debt | 590 | 464 | 154 | 237 | 210 |
| Total debt | 722 | 600 | 288 | 972 | 342 |
EBITDA margin
27.6%
This company
15.8%
Market median
+75% vs market
20212025
Equity ratio
59.0%
This company
38.2%
Market median
+54% vs market
20212025
Return on equity
30.0%
This company
18.4%
Market median
+63% vs market
20212025
Net profit margin
19.7%
This company
8.1%
Market median
+143% vs market
20212025
Asset turnover
0.90×
This company
1.12×
Market median
+20% vs market
20212025
Debt / equity
0.69×
This company
0.62×
Market median
+11% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-10-01 – 2021-09-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SG Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Chairman | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Salusos AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Shadi-Afarin Ghassemi Jahani | Chief Executive Officer | 0 companies |
| Negar Ghassemi | Deputy Board Member | 0 companies |
| Amir Kamran Jahani | Chairman | 0 companies |